Newsletter
FemTech Focus

FemTech Focus

Femtech experts talk about the innovative technology, services, and products that are improving women's health and wellness.

Latest From Series

TMRW's remote automated platform for frozen eggs and embryos – Episode 116

Melanie Goldey is the COO & CFO at TMRW Life Sciences, a fertility tech company bringing safety, security, and automation to the long-term care and storage of the frozen eggs and embryos at the heart of nearly every IVF birth. Before TMRW, Melanie was CFO at Refinery29, where she led the company’s merger with Vice Media Group, creating the largest digital media company in the world, valued at over $4 billion. Prior to Refinery29, Melanie was an executive at Everyday Health, a multi-platform digital healthcare company using data and technology to service patients, professionals, payers, and providers. There, she helped grow the company’s capabilities through acquisitions, a $100 million IPO, and ultimately to acquisition by J2 Global/Ziff Davis for nearly $500 million. Melanie was previously a technology banker at J.P. Morgan. Melanie graduated with her BA in Economics from Wellesley. We discussed the power of community combined with technology, the egg freezing and thawing process, democratizing IVF and fertility services and women in STEM. Check out TMRW at www.tmrw.org Rate, Review & Subscribe!
May 17, 2021

TMRW's remote automated platform for frozen eggs and embryos – Episode 116

Melanie Goldey is the COO & CFO at TMRW Life Sciences, a fertility tech company bringing safety, security, and automation to the long-term care and storage of the frozen eggs and embryos at the heart of nearly every IVF birth. Before TMRW, Melanie was CFO at Refinery29, where she led the company’s merger with Vice Media Group, creating the largest digital media company in the world, valued at over $4 billion. Prior to Refinery29, Melanie was an executive at Everyday Health, a multi-platform digital healthcare company using data and technology to service patients, professionals, payers, and providers. There, she helped grow the company’s capabilities through acquisitions, a $100 million IPO, and ultimately to acquisition by J2 Global/Ziff Davis for nearly $500 million. Melanie was previously a technology banker at J.P. Morgan. Melanie graduated with her BA in Economics from Wellesley. We discussed the power of community combined with technology, the egg freezing and thawing process, democratizing IVF and fertility services and women in STEM. Check out TMRW at www.tmrw.org Rate, Review & Subscribe!
May 17, 2021

Mount Carmel's Women's Heart Program treating the hearts of every woman – Episode 115

Dr. Amrita Karve is the Co-Founder and Co-Director of Women's Heart Program at Mount Carmel Health System. Dr. Karve, MD, FACC, is a cardiologist at Mount Carmel Health System, a large private community health system in Columbus, Ohio. The Women's Heart Program was created to increase awareness of heart disease in women, reduce gender disparities in diagnosis and treatment, and to provide a concierge experience for women of all socioeconomic classes to be more engaged in their health. Dr. Karve is a member and guest speaker for the American Heart Association and is board-certified in internal medicine, cardiovascular disease, and echocardiography. Her special interests include women's health and innovative clinical approaches to obesity medicine. She graduated Magna Cum Laude from George Washington University's BA/MD program in 2004, completed her residency in internal medicine at the University of Michigan in 2014, and cardiology fellowship at Ohio State University in 2017. We discussed underdiagnosis for women's heart diseases, risk factors for women's heart diseases and the women's heart program at the Mount Carmel Health System. Check out The Women's Heart Program at the Mount Carmel Health System at https://www.mountcarmelhealth.com/find-a-service-or-specialty/womens-heart-program/ Rate, Review & Subscribe!
May 12, 2021

Decreasing delayed diagnosis of breast cancer with Gabbi – Episode 114

Kaitlin Christine is the CEO & Founder of Gabbi, a FemTech company aiming to solve delayed diagnosis of preventable diseases that affect women, starting with breast cancer. Kaitlin is a breast cancer survivor and ovarian cancer previvor who has made it her life's mission to empower women to understand their bodies and advocate for themselves. Kaitlin has spent over 9 years in women’s health--working for leading nonprofits, as a sought after national speaker, was the youngest hire for the world’s leading genetic testing company where she led sales and eventually transitioned to a role as a hereditary cancer specialist, and most recently was the VP of Growth for an e-commerce marketing startup. Kaitlin earned her Bachelor of Arts from the University of Denver. We discussed Kaitlin's personal journey with breast cancer, barriers to entry in healthcare, gaps in awareness and innovation for breast cancer. Check out Gabbi at www.begabbi.com Rate, Review & Subscribe!
May 12, 2021

ELANZA Wellness and their behavioral health fertility platform- Episode 113

Catherine Hendy is Co-founder of ELANZA Wellness, a behavioral health coaching platform that helps fertility clinics easily provide lifestyle and emotional support to patients, for better experiences and outcomes. ELANZA was recently selected for Techstars New York, an accelerator program for the world’s most promising startups. Catherine and her cofounder, Brittany Hawkins, started the company after their own experiences of gaps in fertility care and have just launched the ELANZA Wellness Whole Patient Care Initiative - asking clinicians who care about diversity, equity and inclusion, emotional support and patient-centric operations to sign the pledge, as well as past and current patients to share their experiences of care. We discussed types of fertility-related issues, fertility clinics and egg freezing. Check out ELANZA Wellness at www.elanzawellness.com Rate, Review & Subscribe!
May 5, 2021

Menstrual reflux and early diagnosis for endometriosis with Hera Biotech – Episode 112

Somer Baburek is the CEO, President and Co-Founder of Hera Biotech. Hera Biotech is a biotechnology company that was formed to address unmet needs in the field of women’s health and specifically, in reproductive medicine. Hera’s initial goal is to commercialize the MetriDx™, a non-surgical method for the definitive and early diagnosis of endometriosis. Prior to founding Hera, Somer spent 7 years with the largest life science venture capital fund in San Antonio assisting with due diligence activities and served in 2 of the fund’s sister companies as the Director of Clinical Operations. During her time with the companies, she was part of the senior management team that took them from a single investigator-initiated IND to 4 open INDs, saw the successful license of a 5 sku product line to the largest industry participant and successfully managed an End of Phase 2 Meeting with the FDA before they were acquired for $250M USD. Somer took a short break following the exit, while she looked for available technology in her field of passion, women’s health. We discussed menstrual reflux, the stages of endometriosis and endometriosis diagnosis. Check out Hera Biotech at www.herabiotech.com Rate, Review & Subscribe!
May 3, 2021

Listen on your favorite player

New to Podcasts? It's easy to get started!

FemTech Focus

The FemTech Focus Podcast with Dr. Brittany Barreto is a meaningfully provocative conversational series that brings femtech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as femtech) that are improving women's health and wellness.

Though many leaders in femtech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.
View All Episodes

Host

Brittany Barreto, PhD

Brittany Barreto, PhD

Dr. Brittany Barreto is the unconventional serial entrepreneur that proves that anything is possible with hard work and heart. While finishing her PhD in genetics at Baylor College of Medicine, Brittany became the CEO and Co-Founder of the revolutionary dating app Pheramor. The ambitious venture was the first nationwide DNA-based dating app to hit the market, reaching an eager audience that resulted in 50% growth, month over month. Brittany was also successful in fundraising $1.3 million for her startup, her founder’s journey took a pivot three years later when she embarked on a new path as the Senior Venture Associate at Capital Factory, a notable innovation player in Texas.

Under her leadership the Houston accelerator portfolio grew by an impressive 205%. It was also during this time that Brittany realized that Houston needed more former-founder mentors like herself to help usher in the next generation of Femtech startups. Dr. Brittany Barreto now has her sights on advancing the Femtech community through her latest world-changing venture - FemTech Focus.

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
November is COPD Awareness Month! COPD affects millions of people in the US and around the world. Tune into this new podcast miniseries to learn more!